The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: a double-blind, placebo-controlled trial. [electronic resource]
Producer: 19900119Description: 486-95 p. digitalISSN:- 0272-6386
- Adult
- Aged
- Anemia -- drug therapy
- Double-Blind Method
- Erythropoietin -- therapeutic use
- Female
- Hematocrit
- Humans
- Kidney Failure, Chronic -- complications
- Kidney Function Tests
- Male
- Middle Aged
- Potassium -- blood
- Quality of Life
- Randomized Controlled Trials as Topic
- Recombinant Proteins -- therapeutic use
- Renal Dialysis
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.